• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Hyperphosphoremia and hypophosphoremia].

作者信息

Kuntziger H, Altman J J

出版信息

Rev Prat. 1989 Apr 13;39(11):949-53.

PMID:2717867
Abstract

Disorders of phosphate metabolism are caused by a disrupted balance between intestinal absorption and renal excretion or by an altered distribution between intra- and extracellular pools. Hyperphosphatemia per se does not have any clinical effects except for ectopic calfifications. The most frequent cause is chronic renal disease. Other causes - increased tubular reabsorption as seen for instance un hypoparathyroïdism; increased intertinal absorption as seen with vitamin D excess; redistribution to the extracellular pool, as seen with the tumor lysis syndrome, are uncommon; and no one cause is outstanding in frequency. Hypophosphatemia is frequent caused by a redistribution of phosphate to the cellular pool, associated for instance with respiratory alkalosis or infusion of glucose and fructose. Hyperphosphaturia as a cause of hypophosphatemia is seen in primary and secondary hyperparathyroïdism as well as in familial hypophosphatemic rickets. Decreased intake of phosphate may be secondary to intravenous hyperalimentation, chronic ingestion of phosphate-binding antacids or vitamin D deficiency. Hypophosphatemia does not appear to produce any harmful effects. However acute hypophosphatemia, if it occurs in the presence of preexisting cellular injury and phosphate depletion, as in chronic alcoholic patients for instance, has been implicated as a cause of severe clinical syndromes. Chronic hypophosphatemia in children may induce rickets, and osteomalacia in adults.

摘要

相似文献

1
[Hyperphosphoremia and hypophosphoremia].
Rev Prat. 1989 Apr 13;39(11):949-53.
2
[Clinical aspect of recent progress in phosphate metabolism. Hyperphosphatemia and hypophosphatemia].[磷代谢近期进展的临床情况。高磷血症和低磷血症]
Clin Calcium. 2009 Jun;19(6):785-92.
3
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
4
Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease.成纤维细胞生长因子23在慢性肾脏病磷稳态及矿物质代谢紊乱发病机制中的作用
Semin Dial. 2007 Jul-Aug;20(4):302-8. doi: 10.1111/j.1525-139X.2007.00308.x.
5
Hypophosphatemia: an evidence-based problem-solving approach to clinical cases.低磷血症:基于证据的临床病例解决方法。
Iran J Kidney Dis. 2010 Jul;4(3):195-201.
6
Hyperparathyroidism.
Minerva Pediatr. 2004 Feb;56(1):125-31.
7
Metabolic bone disease secondary to renal and intestinal disorders.继发于肾脏和肠道疾病的代谢性骨病。
Calif Med. 1969 May;110(5):397-409.
8
Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia.静脉注射含糖氧化铁诱导的低磷血症:FGF23相关低磷血症的另一种形式。
Bone. 2009 Oct;45(4):814-6. doi: 10.1016/j.bone.2009.06.017. Epub 2009 Jun 23.
9
Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement.成纤维细胞生长因子23(FGF23)检测在低磷血症患者中的临床应用:基于FGF23检测的诊断标准建议
Bone. 2008 Jun;42(6):1235-9. doi: 10.1016/j.bone.2008.02.014. Epub 2008 Mar 5.
10
Hypercalciuria secondary to chronic hypophosphatemia.
Miner Electrolyte Metab. 1994;20(5):255-8.